Therapixel receives FDA 510(k) clearance for MammoScreen™
PARIS, July 9, 2020 /PRNewswire/ — MammoScreen™, the explainable and actionable artificial intelligence (AI) based software assisting Radiologists in reading screening mammograms, received 510(k) clearance K192854 from the U.S. Food and Drug Administration (FDA). This FDA clearance was…
Comments Off on Therapixel receives FDA 510(k) clearance for MammoScreen™